The influence of platelet specific and HLA antibodies was investigated
on primary hemostasis by the in vitro bleeding test (IVBT) (Thrombost
at 4000). Seven of 12 plasmas with HPA-1a (P1(A1)) antibodies and two
with antibodies against glycoprotein Ib/IX significantly inhibited the
IVBT of normal, cross-match-positive donor blood. This correlated wit
h a significant increase of GMP-140 (CD 62) on the platelets, determin
ed by flow cytometry. These results agree with the literature showing
both activation and inhibition of platelet function by platelet specif
ic antibodies. On the other hand, HLA antibodies showed a similar plat
elet activation (shortening of occlusion time and decrease in blood vo
lume in the IVBT, increase of CD 62 expression) as plasma samples of p
olytransfused thrombocytopenic patients without HLA antibodies. It can
be concluded that neither an activating nor an inhibitory effect of H
LA antibodies on platelet function is significant in vivo. The IVBT se
ems not to be suited for compatibility testing.